Company News - Shanghai VKEY Biotechnologies Co.,Ltd.

30

May

Lab's New Favorite! GDP Pre-loading Technology + High Signal-to-Noise Ratio Becomes the 'Gold Standard' for KRAS Drug Screening

Clinical Challenges and Drug Development Opportunities for KRAS[G12D] Mutation The KRAS gene encodes the KRAS protein, a small GTPase that serves as a key molecule in cellular signal transduction, re...

24

May

Exploring the Cutting-Edge Technologyof Tyrosine Kinase—KeyTec® TR-FRET TKs Kinase Kit

Background Tyrosine kinases (TKs) are enzymes that catalyze the phosphorylation of tyrosine residues in proteins, playing a critical role in cellular processes such as growth, proliferation, differen...

03

Apr

VKEY-BIO Successfully Passes ISO9001 Quality Management System Certification

In April 2024, VKEY-BIO successfully passed the ISO9001 Quality Management System Certification and obtained the GB/T 19001-2016/ISO9001:2015 Quality Management System Certification. The scope of cert...

26

Jul

VKEY-BIO was Selected as the 2023 Shanghai Pudong New Area (second batch) Innovative SMEs

Abstract: VKEY-BIO (Shanghai) Biotechnology Co., Ltd. has successfully passed the evaluation for the 2023 Shanghai Pudong New Area (Second Batch) Innovative SMEs. Innovative SMEs refers to ...

04

Jan

VKEY-BIO was Recognized as a High-Tech Enterprise

Abstract: VKEY-BIO (Shanghai) Biotechnology Co., Ltd. has been awarded a national-level qualification certification, officially entering the ranks of national high-tech enterprises (Certificate Issued...